34188709|t|Exosome-derived microRNA-433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non-small cell lung cancer.
34188709|a|Tumor-derived exosomal microRNAs (miRNAs/miRs) serve a vital biological role in tumorigenesis and development, but the effects and underlying mechanisms remain unclear. To explore the impact of exosomal miR-433 in non-small cell lung cancer (NSCLC) and understand its mechanism of action in NSCLC progression, the present study isolated the exosomes from the plasma of patients with NSCLC after chemotherapy and found that miR-433 expression was lower in plasma of patients with resistant NSCLC compared with in plasma of patients with sensitive NSCLC and in normal serum. Additionally, miR-433 expression was markedly negatively associated with a large tumor size, distant metastasis, advanced TNM stage and a poor prognosis in patients with NSCLC. miR-433 inhibited tumor growth by blocking the cell cycle in vitro and in vivo, as well as by promoting apoptosis and T-cell infiltration in the tumor microenvironment. Additionally, miR-433 inhibited chemoresistance to cisplatin by regulating DNA damage. Moreover, miR-433 inactivated the WNT/beta-catenin signaling pathway by targeting transmembrane p24 trafficking protein 5 in NSCLC. Overall, the current findings may provide a potential prognostic biomarker and therapeutic target for patients with NSCLC.
34188709	16	28	microRNA-433	Gene	574034
34188709	38	51	tumorigenesis	Disease	MESH:D063646
34188709	88	91	CD4	Gene	920
34188709	96	99	CD8	Gene	925
34188709	109	135	non-small cell lung cancer	Disease	MESH:D002289
34188709	137	142	Tumor	Disease	MESH:D009369
34188709	217	230	tumorigenesis	Disease	MESH:D063646
34188709	340	347	miR-433	Gene	574034
34188709	351	377	non-small cell lung cancer	Disease	MESH:D002289
34188709	379	384	NSCLC	Disease	MESH:D002289
34188709	428	433	NSCLC	Disease	MESH:D002289
34188709	506	514	patients	Species	9606
34188709	520	525	NSCLC	Disease	MESH:D002289
34188709	560	567	miR-433	Gene	574034
34188709	602	610	patients	Species	9606
34188709	626	631	NSCLC	Disease	MESH:D002289
34188709	659	667	patients	Species	9606
34188709	683	688	NSCLC	Disease	MESH:D002289
34188709	724	731	miR-433	Gene	574034
34188709	791	796	tumor	Disease	MESH:D009369
34188709	811	821	metastasis	Disease	MESH:D009362
34188709	832	835	TNM	Disease	
34188709	866	874	patients	Species	9606
34188709	880	885	NSCLC	Disease	MESH:D002289
34188709	887	894	miR-433	Gene	574034
34188709	905	910	tumor	Disease	MESH:D009369
34188709	1032	1037	tumor	Disease	MESH:D009369
34188709	1070	1077	miR-433	Gene	574034
34188709	1107	1116	cisplatin	Chemical	MESH:D002945
34188709	1153	1160	miR-433	Gene	574034
34188709	1181	1193	beta-catenin	Gene	1499
34188709	1225	1264	transmembrane p24 trafficking protein 5	Gene	50999
34188709	1268	1273	NSCLC	Disease	MESH:D002289
34188709	1377	1385	patients	Species	9606
34188709	1391	1396	NSCLC	Disease	MESH:D002289
34188709	Association	MESH:D002289	1499
34188709	Association	574034	920
34188709	Negative_Correlation	1499	574034
34188709	Negative_Correlation	MESH:D063646	574034
34188709	Association	MESH:D002945	574034
34188709	Negative_Correlation	MESH:D009369	574034
34188709	Association	50999	574034
34188709	Association	MESH:D063646	925
34188709	Negative_Correlation	MESH:D002289	574034
34188709	Association	MESH:D002289	50999
34188709	Association	574034	925
34188709	Association	1499	50999
34188709	Association	MESH:D002289	925

